Phase II, Multicenter, Single-Arm, Feasibility Study of Eribulin Combined With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive, Early-Stage Breast Cancer
Clinical Breast Cancer - United States
doi 10.1016/j.clbc.2015.07.007
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2016
Authors
Publisher
Elsevier BV